Drug maker Cadila Healthcare through its fully-owned subsidiary Zydus Animal Health Ltd. (ZAHL) has signed a share purchase agreement with private equity fund ICICI Venture to acquire 100 percent shareholding of Germany-based Bremer Pharma GmbH for an undisclosed amount.